Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
about
Discovery of new anticancer agents from higher plantsDiscovery of Anticancer Agents of Diverse Natural OriginCytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).Proteasome-inhibitory and cytotoxic constituents of Garcinia lateriflora: absolute configuration of caged xanthones.The continuing search for antitumor agents from higher plantsBioactivity-guided isolation of cytotoxic sesquiterpenes of Rolandra fruticosa.Potent cytotoxic arylnaphthalene lignan lactones from Phyllanthus poilaneiInvestigation of Vietnamese plants for potential anticancer agents.Goyazensolide Induces Apoptosis in Cancer Cells in vitro and in vivo.Anticancer and Anti-Inflammatory Activities of a Standardized Dichloromethane Extract from Piper umbellatum L. Leaves.The relevance of higher plants in lead compound discovery programs.A potential oral anticancer drug candidate, Moringa oleifera leaf extract, induces the apoptosis of human hepatocellular carcinoma cells.Bioactive constituents of Indigofera spicata.Secondary Metabolites from Polar Organisms.Synthesis of cytotoxic palmerolides.The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia.Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis.Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonistAn Ethnopharmacological, Phytochemical and Pharmacological Review on Lignans from Mexican spp
P2860
Q27006814-196A376E-341F-4786-BB16-968C14026324Q28068341-8D752050-F062-434E-A31C-A81D33A50D89Q33511322-94650B6B-1D67-4096-9D22-46346A83307EQ33668632-F47E53DF-F15E-4A8F-A452-7FA8E86859ABQ33717343-E3BDB94E-98B6-491D-A748-744538FA703AQ33761392-80A581CE-93E5-4F66-BDAF-6F21189007BAQ33815679-8662537F-EE31-42C2-880C-92D46A7D71FBQ34478640-ABCD2E52-84D7-404B-BE98-F403A5FEB98AQ35000591-6844A697-9B98-4870-9D02-203CD7A0EFD1Q35096620-E7CDAA70-8881-47FF-8AFD-6E58C8292163Q35172533-D771C169-EBA4-4F6B-AE04-E5293C9884CEQ35943094-1BE34F36-9073-429E-A2BB-D776E66487C2Q37250396-0D54015D-C204-4F52-AC18-75611B4970AFQ37721787-05F796FE-7B24-460D-89BD-44F5A3FFE0B1Q38163949-F0B75D58-350F-4743-8BEC-0463C7825DF1Q39302268-20800625-926F-4934-B0E3-AB0C5C784B06Q39413220-9FC9EC9B-F10D-40FD-80B5-8B9BA4062C53Q58692179-49CAD7C7-06BD-4016-8925-5F915060832EQ58692547-81368426-FE55-48FB-A2EE-C4FAD0188F53
P2860
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@en
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@nl
type
label
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@en
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@nl
prefLabel
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@en
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery.
@nl
P2093
P2860
P356
P1476
Use of the in vivo hollow fiber assay in natural products anticancer drug discovery
@en
P2093
John M Pezzuto
Mansukh C Wani
Norman R Farnsworth
Steven M Swanson
P2860
P304
P356
10.1021/NP800767A
P50
P577
2009-03-01T00:00:00Z